AFYA Share Price Performance
US$15.20
-1.20 (-7.32%)
7.9% overvalued intrinsic discount
US$14.09
Fair Value
Price US$15.20
AnalystLowTarget US$14.09
AnalystConsensusTarget US$18.78
AnalystHighTarget US$25.04
Fair ValueUS$14.42
Share Pricen/a
Afya Limited Stock Price
- 4 Narratives written by author
- 0 Comments on narratives written by author
- 32 Fair Values set on narratives written by author
AFYA Community Narratives
AN
Fair Value US$14.42 5.4% overvalued intrinsic discount
AI Advances And Brazil Instability Will Shrink Traditional Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$18.78 19.1% undervalued intrinsic discount
Brazil Medical Education And Digital Trends Will Secure Future Opportunity
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
Fair Value US$25.62 40.7% undervalued intrinsic discount
Telehealth And Brazil's Aging Population Will Transform Medical Education
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AFYA Market Outlook
Afya Limited (NASDAQ: AFYA) is a Brazilian company specializing in medical education and digital health services. Sector: Education Industry: Medical Education Market Capitalization: $1.4b (small cap) Major Competitors: Afya Limited (NASDAQ: AFYA) is a prominent player in Brazil's medical education sector.Read more
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
NA
US$14.86
2.3% overvalued intrinsic discount
NateF Fair Value
Revenue
9.72% p.a.
Profit Margin
18.2%
Future PE
15.01x
Price in 2030
US$24.57
Brazil Medical Education And Digital Trends Will Secure Future Opportunity
Key Takeaways Expanding medical education offerings and digital initiatives are strengthening revenue growth, operating leverage, and profitability through increased student intake and higher-margin recurring revenues. Operational efficiencies and disciplined acquisitions are enhancing margin expansion, earnings stability, and long-term market share in the Brazilian medical education sector.Read more
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
US$18.78
19.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
7.97% p.a.
Profit Margin
25.62%
Future PE
11.37x
Price in 2028
US$25.51
Telehealth And Brazil's Aging Population Will Transform Medical Education
Key Takeaways Afya is poised for sustained, above-consensus growth and margin expansion due to Brazil's physician shortage, demographic forces, and digital health penetration. Scalable operations, accretive acquisitions, and strong capital allocation establish Afya as a dominant consolidator and digital infrastructure leader in Brazilian healthcare education.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$25.62
40.7% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue
9.71% p.a.
Profit Margin
32.26%
Future PE
11.52x
Price in 2028
US$34.75
AI Advances And Brazil Instability Will Shrink Traditional Demand
Key Takeaways Rapid growth of AI-powered and online education threatens Afya's traditional offerings, increasing competition and risking erosion of market share and pricing power. Macroeconomic instability, demographic shifts, and rising regulatory pressures in Brazil constrain enrollment growth and could compress margins and profitability.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$14.42
5.4% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
5.68% p.a.
Profit Margin
23.9%
Future PE
9.72x
Price in 2028
US$19.52
Trending Discussion
Recently Updated Narratives
NA
AFYA Market Outlook
Fair Value: US$14.86 2.3% overvalued intrinsic discount
8 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Brazil Medical Education And Digital Trends Will Secure Future Opportunity
Fair Value: US$18.78 19.1% undervalued intrinsic discount
13 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI Advances And Brazil Instability Will Shrink Traditional Demand
Fair Value: US$14.42 5.4% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Afya Limited Key Details
About AFYA
- Founded
- 1999
- Employees
- n/a
- CEO
- WebsiteView website
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.
